Cancer research. As questions grow, Duke halts trials, launches investigation.
作者信息
Couzin-Frankel Jennifer
出版信息
Science. 2010 Aug 6;329(5992):614-5. doi: 10.1126/science.329.5992.614.
PMID:20688986
Abstract
摘要
相似文献
1
Cancer research. As questions grow, Duke halts trials, launches investigation.
Science. 2010 Aug 6;329(5992):614-5. doi: 10.1126/science.329.5992.614.
2
Targeted therapy and pharmacogenomic programs.
Cancer. 2003 Apr 15;97(8 Suppl):2076-82. doi: 10.1002/cncr.11287.
3
Improving the evaluation of new cancer treatments: challenges and opportunities.
Nat Rev Cancer. 2003 Apr;3(4):303-9. doi: 10.1038/nrc1047.
4
Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
J Clin Oncol. 2007 Oct 10;25(29):4642-7. doi: 10.1200/JCO.2007.11.2482.
5
Genetic profiling can predict chemotherapy side effects and treatment response.
Expert Rev Mol Diagn. 2003 Jul;3(4):406-7.
6
[Scientific reporting guidelines].
Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2340. doi: 10.4045/tidsskr.09.1099.
7
Clinical medicine. Biomarker tests need closer scrutiny, IOM concludes.
Science. 2012 Mar 30;335(6076):1554. doi: 10.1126/science.335.6076.1554.
8
Duke scandal highlights need for genomics research criteria.
J Natl Cancer Inst. 2011 Jun 22;103(12):916-7. doi: 10.1093/jnci/djr231.
9
AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 4.
IDrugs. 2007 Dec;10(12):844-7.
10
What information should be required to support clinical "omics" publications?
Clin Chem. 2011 May;57(5):688-90. doi: 10.1373/clinchem.2010.158618.
引用本文的文献
1
Reuse of public genome-wide gene expression data.
Nat Rev Genet. 2013 Feb;14(2):89-99. doi: 10.1038/nrg3394. Epub 2012 Dec 27.
Zotero 插件